Drug Information

General Information
Drug ID
DR00242
Drug Name
Glycine
Synonyms
(1-13c)glycinato; (15N)Glycine; 2,2-dialkylglycines; 2-Aminoacetic acid; AB-131/40217813; AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER; Acide aminoacetique; Acide aminoacetique [INN-French]; Acido aminoacetico; Acido aminoacetico [INN-Spanish]; Acidum aminoaceticum; Acidum aminoaceticum [INN-Latin]; Aciport; Aminoacetic acid; Aminoazijnzuur; Aminoessigsaeure; Aminoethanoic acid; Amitone; An alpha amino acid ester; Corilin; GLY (IUPAC abbrev); GLYCINE 1.5% IN PLASTIC CONTAINER; GLYCINE, ACS; Glicina; Glicina [INN-Spanish]; Glicoamin; Gly; Glycin; Glycine (JP15/USP); Glycine [INN]; Glycine iron sulphate (1:1); Glycine, homopolymer (VAN); Glycine, labeled with carbon-14; Glycine, non-medical; Glycine-UL-14C hydrochloride; Glycinum; Glycinum [INN-Latin]; Glycocoll; Glycolixir; Glycosthene; Glykokoll; Glyzin; Gyn-hydralin; H-Gly-OH; H2N-CH2-COOH; Hampshire glycine; Hgly; L-Glycine; L-alpha-amino acids; Leimzucker; Padil; Polyglycine; Polyglycine II; S04-0135; Sucre de gelatine
Drug Type
Small molecular drug
Indication Dietary shortage [ICD11: 5B7Z] Approved [1]
Therapeutic Class
Dietary supplement
Structure
3D MOL 2D MOL
Formula
C2H5NO2
Canonical SMILES
C(C(=O)O)N
InChI
InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
InChIKey
DHMQDGOQFOQNFH-UHFFFAOYSA-N
CAS Number
CAS 56-40-6
Pharmaceutical Properties Molecular Weight 75.07 Topological Polar Surface Area 63.3
Heavy Atom Count 5 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
-3.2
PubChem CID
750
PubChem SID
10527483 , 11113413 , 11528254 , 14747327 , 16955354 , 17404564 , 24439112 , 24775647 , 24849510 , 24860042 , 24865701 , 24873323 , 24895210 , 24895217 , 24895290 , 24895306 , 24895353 , 24895355 , 24898980 , 24901611 , 26718882 , 26751653 , 3133349 , 3339 , 33728423 , 37415007 , 46295148 , 585843 , 589752 , 626974 , 6435754 , 7346033 , 7847079 , 7887927 , 7979426 , 8026292 , 8026825 , 8138085 , 8145759 , 8150769 , 827140 , 829229 , 829387 , 830123 , 833865 , 836630 , 836631 , 838484 , 841093 , 86929
ChEBI ID
ChEBI:15428
TTD Drug ID
D0M8AB
DT(s) Transporting This Drug ASCT2 Transporter Info Alanine/serine/cysteine/threonine transporter 2 Substrate [2]
BGT1 Transporter Info Na(+)/Cl(-) betaine/GABA transporter Substrate [3]
GLYT1 Transporter Info Sodium- and chloride-dependent glycine transporter 1 Substrate [4]
GLYT2 Transporter Info Sodium- and chloride-dependent glycine transporter 2 Substrate [5]
LAT2 Transporter Info L-type amino acid transporter 2 Substrate [6]
PAT1 Transporter Info Proton-coupled amino acid transporter 1 Substrate [7]
Drug-Transporter Activity Data
Drug-Transporter Activity Data ASCT2 Transporter Info Km = 320 microM HRPE cells-ASCT2 [2]
References
1 Cannabidiol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1046-53.
3 Interpreting metabolomic profiles using unbiased pathway models. PLoS Comput Biol. 2010 Feb 26;6(2):e1000692.
4 Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans. Hum Genet. 2016 Nov;135(11):1263-1268.
5 Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem. 2012 Aug 17;287(34):28975-85.
6 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20)
7 Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells. Eur J Pharm Sci. 2008 Sep 2;35(1-2):86-95.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.